We investigated the production of hyaluronan and the presence of hyaluronan receptors in a panel of human lung carcinoma cell lines, consisting of small cell carcinomas (SCLC) and non-small cell carcinomas (non-SCLC). These transformed cell lines produced only minute amounts of hyaluronan, whereas normal lung fibroblasts synthesized high amounts. 
INTRODUCTION
Hyaluronan is a linear polysaccharide that provides stability and elasticity to the extracellular matrix. Moreover, due to its unique rheological properties, use of hyaluronan has been advantageous in different medical conditions (reviewed in Ref. l) . Furthermore, some invasive tumor cells express hyaluronan receptors (2, 3) and are surrounded with hyaluronan-enriched extracellular matrices (4) . The tumor-associated hyaluronan is either produced by the tumor cells (5, 6) or the tumor cells secrete factors that stimulate hyaluronan synthe sis by adjacent connective tissue cells (4, 7) . Underlying functional properties of hyaluronan are its interactions with specific cell surface receptors and extracellular matrix proteins. Hyaluronan receptors have been detected on several cell types (reviewed in Refs. 8 and 9) .
A putative hyaluronan receptor of Mr 85,000 has been shown to be closely related to the CD44 family of glycoproteins. CD44 occurs in different forms that arise through differential splicing of the gene and different degrees of glycosylation (10) . One "standard" form of CD44 (CD44s; M, 85,000-90,000) binds hyaluronan (11) and is expressed in large amounts on a variety of malignant tumors (3, 12) . The "variant" isoforms of CD44 (CD44v) contain sequences encoded by the variant exons, are usually unable to bind hyaluronan, and are expressed preferentially in epithelium (13, 14) . Another putative hyaluronan receptor, termed RHAMM1 (15) , promotes cell locomo tion and focal adhesion turnover (16) .
Lung cancers can be divided into two major groups, SCLC and non-SCLC ( 17) . Non-SCLC represents around 70% of the lung cancer cases (18) and may be subgrouped into ADC, SQC, and LCC (19) . Non-SCLC cell lines, but not the SCLC lines, express genes for PDGF-AA and PDGF-BB, TGF-a, TGF-ÃŸ,and insulin growth factor-II (20) . It has been suggested that non-SCLCs synthesize and release growth factors that may be involved in the generation of connective tissue (21) . It has been shown that lung neoplasms are surrounded with hyaluronan-enriched extracellular matrix (22) . The production of hyaluronan is stimulated by certain growth factors, such as PDGF, TGF-ÃŸ,epidermal growth factor, and insulin-like growth factor-I (23) (24) (25) .
The aim of the present study was to investigate the mechanisms involved in the accumulation of tumor-associated hyaluronan in lung cancer patients. Furthermore, to study the interactions between lung cancer cells and host tissue, we investigated whether lung carcinoma cells possess hyaluronan receptors. We demonstrate the presence of saturable and functionally active specific hyaluronan-binding sites on a human SQC cell line.
MATERIALS AND METHODS
Materials. Radioactive hyaluronan. labeled with 'H in the acetyl groups (['H]hyaluronan; 38 fig/ml; 14 X 10'' dpm/ml) was a generous gift from Dr. J. R. E. FrÃ¤ser(Melbourne. Australia). Hyaluronan of Mt 1.3 X IO'1was kindly provided by O. Wik (Pharmacia, Uppsala, Sweden). Monoclonal anti-human CD44 clone A3D8 biotin conjugate and goat anti-rabbit IgG TRITC conjugate were obtained from Sigma Chemical Co. (St. Louis, MO). Human CD44 mAbs Hermes-1 (rat IgG 2a; serum-free supernatant) and Hermes-3 (mouse IgG 2a; concentrated serum-free supernatant; 0.5 mg/ml) as well as mAbs against syndecan (rat IgG 2a; serum-free supernatant, class-matched negative control for Hermes-1) were generously provided by Dr. S. Jalkancn (Turku, Finland). Polyclonal antibodies R 3.6 raised against a peptide sequence in RHAMM were kindly provided by Drs. R. Savani and E. Turley (Winnipeg, Manitoba, Canada) . TRITC-labeled avidin D was purchased from Vector Laboratories.
Cells and Cell Culture Conditions. A panel of established human lung carcinoma cell lines was used: SCLCs U-1690, U-2020 (26), H-69 and H-82 (18) ; ; SQCs U-1752 (26); and LCCs H-157, U-1810 (26) and H-661 (18) . Normal human lung fibroblasts 507 Hal (27) were kindly provided by Dr. B. Westcrmark (University Hospital, Uppsala, Sweden). The cell lines were routinely cultured in RPMI 1640 (carcinoma cell lines) and DMEM (fibroblasts), supplemented with 10% PCS, 4 mM L-glutamine, 100 lU/ml penicillin, and 100 u,g/ml streptomycin (complete media).
Hyaluronan Synthesized by Human Lung Carcinoma Cell Lines. Subconfluent cell cultures (5-25 X IO6 cells, depending on cell size) were grown in complete RPMI 1640. After 24 h, the cells were washed once and then incubated for an additional 48 h in 20 ml of the same medium. The hyaluronan content in the culture media was analyzed using a commercial kit (Hyaluronan Test 50; Pharmacia, Uppsala. Sweden).
HYALURONAN BINDING SITES ON A SC'LC C'KLL LINK
Preparation of Conditioned Media from Human Lung Carcinoma Cell I,Â¡lies. Cell monolayers or floating aggregates from each carcinoma cell line (10 X IO6 cells), grown in 75-cnr Falcon bottles in complete RPMI 1640, were washed once with serum-free medium and then incubated overnight in the same medium. Both of these media were discarded. To obtain conditioned media, 15 ml fresh serum-free media were then added, and the cells were cultured for 48 h. Then, the conditioned media were added at 75% concentra tion in relation to culture media (v/v; 0.5 ml final volume) to quiescent normal human lung t'ihroblast cultures, obtained after culturing for 24 h in scrum-free DMEM containing glutamine and antibiotics. Following 24 h of incubation, hyaluronan secreted into the culture medium was determined as described above.
Hyaluronan Binding Assay. The ability of intact lung carcinoma cells to bind |'H]hyaluronan was tested essentially as described by Asplund and Heldin (3) . Briefly, subconfluent cell layers were cultured overnight in RPMI Ui4() containing 0.1% PCS and glutamine. As a control, a mAb against CD44, which has no effect on hyaluronan binding (Hermes-3), was used as well as a mAb against syndecan of the same immunoglobulin class as 30) . In other experiments, a peptide antiscrum (R 3.6) generated against a region of RHAMM involved in hyaluronan binding (31) was tested for its ability to inhibit hyaluronan binding.
Detection of (1) followed by 6 h of incubation. The medium was then removed, and cells were treated with 5% (w/v) trichloroacetic acid for 20 min at 4Â°C. After two washes with distilled water, the precipitated DNA was dissolved in 1 M of NaOH for 30 min at room temperature, and samples were subjected to scintillation counting.
[3H]Hyaluronan Degradation Assay. U-1752 cells were cultured in a 35-mm dish at 37Â°Cfor 16 h in RPMI 1640 serum-free medium containing 1 fig/ml of ['Hjhyaluronan. The medium and washes were combined, and the cell layer was dissolved in 0.3 MNaOH containing I % SDS for 30 min at room temperature. Medium and washings as well as cell layer were applied sepa rately to 10 x 130-mm G-50 Sephadex Superfine columns (Pharmacia, Uppsala, Sweden) and elutcd with 0.05 M sodium acetate buffer at pH 6.0 containing 0. l M NaCI. Four hundred >xlfractions were collected. The columns were standardized with [3H|hyaluronan and 'H^O. Table 1 , hyaluronan is not produced in large amounts by the lung carcinoma cell lines; the amount of hyaluronan released into the culture medium from 1 X 10'' cells within 48 h (the hyaluronan content in 10% PCS has been subtracted) was lower than the amounts secreted by normal lung fibroblasts (3 X IO4 cells) cultured for 24 h (Fig. 1) . Since increased amounts of hyaluronan are seen in lung cancers (22) , we investigated whether the conditioned media of tumor cell lines possess hyaluronan stimulatory activity for normal lung fibroblasts. Only conditioned media of the ADC cell line H-23, tested at a concentration of 75% in culture medium (v/v), exhibited hyaluronan stimulatory activity similar to that of 10% PCS when tested on quiescent human lung fibroblasts (Fig. 1) . The con ditioned media from the other tumor cell lines had less effect on the stimulation of hyaluronan synthesis. Thus, it is possible that only some of the lung tumors secrete factors that stimulate hyaluronan synthesis by neighboring fibroblasts or other cell types. The secretion of such factors may be related to the variability in the formation of fibrous stromata surrounding cancer cells from the non-SCLC category (21) . To examine whether cell contact is required for the Table 1 Comparison of hyalni'oniin protiiii'tion, h\tilnrtinan binding acti\'il\: ami i'.v/?/r.v.v/V)/i of CD44 unti KHAMM h\ human llin^can-intHita re// lint'\ The amounts of hyaluronan released into the culture media were measured using a commercial test as described in "Materials and Methods." The specific binding of [ Hjhyaluronan (0.25 fig/ml) to lung carcinoma cells (1 x H)'' cells) was determined by subtraction of the radioactivity retained after the addition of nonlabeled hyaluronan (100 /Ag/ml). The data shown is the mean Â±SEM from three different experiments. Relative amounls of CD44 and RHAMM were determined by immunocytochcmistry using mAbs against CD44 or polyclonal antibodies against RHAMM. We also investigated immunochemically the expression of CD44 (mediates lymphocyte homing and tumor cell migration; Refs. 14 and 32) and RHAMM (mediates the motility of H-ra.v transformed fibro blasts; Ref. 33) by the lung tumor cell lines. As shown in Table 1 and Fig. 3 , the SCLC cell line H-69 exhibited high fluorescence intensity when stained with RHAMM antibodies (Fig. 3b) , whereas it showed very little or no fluorescence with CD44 antibodies (Fig. 3a) . The same pattern was observed in all SCLC cells tested (Table 1) . Among the non-SCLC cell lines, the ADC cell line H-125 (Fig. 3, c and d) and SQC cell line U-1752 (Fig. 3 . e and/) stained with both antibodies (Fig. 3, c and e, CD44 antibodies; Fig. 3, d and/ RHAMM antibod ies). The staining for RHAMM in H-125 and U-1752 cells occurred intracellularly in the perinuclear region. In contrast, the LCC cell line U-1810 was also positive for CD44 (Fig. 3g) Fig. 3/i) .
RESULTS

Hyaluronan Production by Human Lung Carcinoma Cell Lines. As shown in
Effect of CD44 and RHAMM Antibodies on Hyaluronan Bind ing. Because the SQC cell line U-1752, which possesses highly specific hyaluronan binding sites, was stained both with mAbs to CD44 and RHAMM, we investigated whether the hyaluronan-binding activity was due to the expression of CD44 or RHAMM molecules. As shown in Table 2 , mAbs to Hermes-1 antigen blocked about 99% of the [3H]hyaluronan-binding activity. mAb Hermes-3 was used as a control, which has been reported not to affect the hyaluronan binding, as well as anti-syndecan of the same immunoglobulin class as mAbs to Hermes-1 antigen; these antibodies had no effect on hyaluronan binding. RHAMM antibodies, although tested at high concentrations, failed to block the binding of most cells tested ( Table 3 ). The 2-fold increase in hyaluronan-binding capacity observed on the cell surface of SQC cells was due to an up-regulation of CD44 molecules, since mAbs to Hermes-1 antigen blocked the binding of [3H]hyaluronan (Table 4) (Table 3 ) but also induced disassembly of the cells (Fig. 4, c and d) . No disassembly among other non-SCLC cells tested was seen (data not shown). After 4 h of treatment, the U-1752 cells started to separate from each other (data not shown). Interestingly, when PMA was added simultaneously with 1 mg/ml hyaluronan, the PMA-induced cell disaggregation was prevented (Fig. 4e) . These results indicate that the hyaluronan-binding sites are saturated by the exogenously added hyaluronan that anchor the cells together. The effect of hyaluronan on cell disassembly was concentration dependent and was maximal at 1 mg hyaluronan/ml; an additional increase had no additional effect (data not shown). Addition of hyaluronan as late as 8 h after PMA treatment inhibited the PMA-induced abrogation of cell-cell adhesion (Fig. 4/) incubated in the presence of DMSO were used as controls; even after 24 h of incubation, cells were still growing in colonies (Fig. 4,  a and h) .
CD44-like Hyaluronan Receptors Expressed on the Squamous Cell Carcinoma Cell Line U-1752 Are Not Involved in the Deg radation of Hyaluronan. Our finding that no or very small amounts of hyaluronan were secreted into the culture medium of U-1752 cells (Table 1) , together with our previous observation that CD44 partici pates in the uptake and degradation of hyaluronan (35), prompted us to investigate whether hyaluronan receptors on U-1752 cells Table 2 25 fig/ml ) was added. Specific binding was determined by subtraction of the radioactivity retained after the addition of high molecular weight nonlabeled hyaluronan ( 100 Â¿ig/ml). The data shown is the mean of duplicates * variation from a representative experiment. (Fig. 5) . In comparison, about 70% of labeled hyaluronan added to the culture medium of rat liver endothelial cells was degraded under these conditions (36). Thus, internalization of hyaluronan was not the explanation for the minute amounts of hyaluronan in the condi tioned medium of U-1752 cells.
DISCUSSION
We show in this study that in a panel of lung carcinoma cell lines, only the SQC cell line U-1752 expresses functional CD44-like hyaluronan-binding sites. The fact that CD44 molecules with the capacity to bind hyaluronan are expressed only on the SQC cell line, but not on other types of lung carcinoma cell lines, makes it a promising candi date as a squamous cell carcinoma lineage differentiation marker. Moreover, PMA treatment of lung carcinoma cells was found to promote disaggregation of U-1752 cells but not of the other cell types. Exogenously added hyaluronan counteracted the PMA effect and promoted cell-cell adhesion. Interestingly, none of the human lung carcinoma cell lines investigated produced high amounts of hyaluronan.
Detection of CD44 by immunostaining (Table 1 ; Fig. 3 ) revealed considerable heterogeneity in the levels of CD44 expressed on non-SCLC cell lines and little or no expression on the highly metastatic SCLC cells. The expression of CD44 on the non-SCLC cell lines H-125, U-1752, and H-157 and on the SCLC cell line H-69 has also been studied previously (37) with similar results as those presented here. Two exceptions are the cell lines H-157 and H-69 that were found by Penno et al. (37) to have a high or intermediate expression of CD44, respectively, whereas we found only a weak expression.
We found that both the SQC and the ADC line H-125 expressed large amounts of CD44 (Table 1) , but only the SQC line expressed functionally active CD44/hyaluronan receptors. It is possible that this is due to differences in glycosylation or other posttranslational mod ifications of CD44, which have been shown to be of importance for its interaction with hyaluronan (reviewed in Ref. 38) . The physiological relevance of hyaluronan-CD44 interactions is unclear. The hyaluronan binding to CD44 molecules may serve to anchor the cells to hyaluronan-rich tissues. If so, one may speculate that the lower metastatic potential of SQC cells compared with SCLC cells may be due to the fact that those cells interact more strongly with hyaluronan-rich mat rices. Nonetheless, several other observations suggest that hyaluronan-CD44 interactions play causative role in tumor dissemination (39). Of particular relevance in this context is the response of the SQC cell line U-1752 to PMA, which promoted hyaluronan-CD44 interac- Table 4 Effect of inAbs against CD44 on hyaltironan-binding activity after treatment with PMA in sqitamous cell lung carcinoma U-1752 cells Cells were incubated in absence or presence of 20 nM PMA for 24 h. [3H]Hyaluronan (0.25 /xg/ml) was added to lung carcinoma cell suspensions (1 X IO6 cells; 100-/il total volume) after preincubation with antibodies for 30 min at room temperature. Specific binding was determined by subtraction of the radioactivity retained after the addition of high molecular weight nonlabeled hyaluronan (1(X) /xg/ml). The data shown are the mean of duplicates Â± variation from a representative experiment. tions (Table 3) and inhibited cell-cell and cell-extracellular matrix interactions (Fig. 4, c and d) . It has been reported that long-term exposure of T lymphocytes to tumor promoters such as PMA is associated with abrogation of T-lymphocyte adhesiveness to matrix proteins and to a decrease in cellular levels of PKC (40). Moreover, other studies suggested that the binding of CD44 to the cytoskeletal protein ankyrin, which is regulated through PKC-mediated phosphorylation (41, 42), is important for the hyaluronan-mediated adhesion in CD44-expressing cells. Because hyaluronan was found to inhibit the PMA-induced cell dissemination and to promote cell-cell adhe sion, it is possible that in vivo the large amounts of hyaluronan synthesized by lung fibroblasts may inhibit the invasiveness and ability to form metastasis of certain lung tumor types. Additional studies are needed to elucidate the molecular mechanisms that regulate hyaluronan-mediated cell-cell and cell-extracellular ma trix interactions and the possible importance of PKC phosphorylation of CD44.
